2021
DOI: 10.1016/j.niox.2021.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Inhaled nitric oxide in adults with in-hospital cardiac arrest: A feasibility study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2022
2022
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 19 publications
0
3
0
1
Order By: Relevance
“…By contrast, when present, NO reduces injuries and has neuroprotective properties in ischemia/reperfusion animal models, both in relation to stroke and cardiac arrest [ 88 ]. For this reason, a prospective trial has been performed, proving the feasibility of iNO administration in cardiac arrest, and showing promising results in terms of survival [ 89 ]. In subarachnoid hemorrhage, NOS inactivation is associated with alterations in microvascular density and hemostasis, leading to rebleeding, intracranial hypertension, and larger hemorrhage volume [ 90 ].…”
Section: Reactive Nitrogen Speciesmentioning
confidence: 99%
“…By contrast, when present, NO reduces injuries and has neuroprotective properties in ischemia/reperfusion animal models, both in relation to stroke and cardiac arrest [ 88 ]. For this reason, a prospective trial has been performed, proving the feasibility of iNO administration in cardiac arrest, and showing promising results in terms of survival [ 89 ]. In subarachnoid hemorrhage, NOS inactivation is associated with alterations in microvascular density and hemostasis, leading to rebleeding, intracranial hypertension, and larger hemorrhage volume [ 90 ].…”
Section: Reactive Nitrogen Speciesmentioning
confidence: 99%
“…In a pilot study including 20 adult IHCA patients receiving inhaled NO at a dose of 40 ppm immediately after ROSC for 24 hours and 199 IHCA controls [ 17 ], patients receiving NO had higher rates of survival to discharge compared to controls, yet no difference in the favorable neurologic outcome was observed. In a secondary analysis of phase I clinical trials including 82 adult OHCA patients, IV nitrite (25 mg or 60 mg) administration during resuscitation resulted in increased cyclic guanosine 3',5'-monophosphate (cGMP) and nitrated conjugated-linoleic acid (NO 2 -CLA) levels, which are responsible for nuclear factor erythroid 2–related factor 2 (Nrf2)-dependent antioxidant gene expression and inhibiting nuclear factor kappa B (NF-κB) regulated pro-inflammatory signaling.…”
Section: Neuroprotective Approaches In Ca-induced Brain Injurymentioning
confidence: 99%
“…В 2019 г. J.K. Patel et al использовали ингаляции оксида азота у пациентов с внутрибольничной остановкой сердца. В пилотном исследовании ингаляции NO в концентрации 40 частей на миллион (ppm) в течение 24 ч в сочетании с гипотермией ассоциировались со значительно более высокими показателями выживаемости, но не влияли на неврологический исход [24]. [25].…”
Section: рациональная фармакотерапияunclassified